about
Management of HIV Infection during Pregnancy in the United States: Updated Evidence-Based Recommendations and Future Potential PracticesPregnancy and virologic response to antiretroviral therapy in South AfricaAntiretroviral therapeutic drug monitoring in Canada: current status and recommendations for clinical practiceHighly active antiretroviral therapy versus zidovudine/nevirapine effects on early breast milk HIV type-1 Rna: a phase II randomized clinical trialPrevalent pregnancy, biological sex, and virologic response to antiretroviral therapyPopulation pharmacokinetics of abacavir in pregnant women.Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapyModified renal function in pregnancy: impact on emtricitabine pharmacokinetics.Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsRepresentation of women and pregnant women in HIV research: a limited systematic review.Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults.Pituitary and brain dopamine D2 receptors regulate liver gene sexual dimorphismPharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection.Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.Long-term treatment of patients with HIV-1: the role of atazanavirAn update on the use of Atripla in the treatment of HIV in the United States.Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum.Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure.German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception.Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV.Individualization of antiretroviral therapy.Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancyUsing pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation.Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.Protein binding of lopinavir and ritonavir during 4 phases of pregnancy: implications for treatment guidelines.Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant womenPharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.Etravirine Pharmacokinetics in HIV-Infected Pregnant Women.Reduced indinavir exposure during pregnancy.Role of atazanavir in the treatment of HIV infectionAtazanavir: its role in HIV treatmentPractical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationInfluence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.Lopinavir exposure with an increased dose during pregnancy.
P2860
Q26738453-F4DA60FA-0C92-4CC0-8E7F-10FF1B087F93Q28741879-1B39D2AF-7304-4E24-82C1-40DF593160B8Q33681426-523DBB80-78F8-4855-B366-E951D54B56BDQ33811136-06BB45F8-D6BC-46FB-93E0-18CF2637AC1FQ34226031-7F74A7A0-FF94-4A18-ADD1-D43FC4159224Q34299084-5615E640-11D8-40E2-B496-B70DBAFCB2BDQ34631738-4CFB166B-338A-47AA-B094-487E57C29125Q34635554-E990B63C-A5FB-4E76-8664-0AC96D7A6D40Q34730950-F29088F7-95FC-4CE9-9495-574B6D7EA985Q34979789-E38DE225-609F-418F-82BD-B3353D2452D7Q35079510-5E243D57-FDC7-4AE9-B797-24F360A919E7Q35088812-17003A71-74FC-488D-B8FE-0E6D9DF4CD72Q35102702-A3AEC0BA-0CDF-4870-9D59-8509046084F9Q35557216-A18C9408-D414-48D1-9517-C621640CEDC9Q35557219-A31955B6-E3DD-491C-83FC-9EEB23B364C0Q35557269-BD3759F9-A17C-42CA-94A4-1D0EBD528714Q35689342-7FF0C97D-0D3D-4822-912E-C7F2041F029EQ35691909-08A3C15F-67F3-46E6-A184-2CF4CCBF614DQ35784583-E8F4CD6E-02A7-435D-8B34-666138D47367Q35827743-3A810E04-3111-444F-A721-74DDAEF94569Q35894019-FC7794F1-2665-4AB1-B34F-7EDF96AC0DB1Q35960319-919281B5-F6CE-4970-A06E-5296E5EE0F8DQ35960706-1E99E4FA-BF8F-4CD1-8B92-BFD172A50DC1Q36052959-FE33A02A-3343-4E16-A9F2-56FF3776DCDFQ36193307-D818C5B5-528B-41C8-BD10-132E75FD90F8Q36429712-B3D29A1F-38B2-4ABD-8144-0BEC6A916817Q36441423-1163A9DA-1590-41E8-B463-50BD9F7A35B0Q36538758-8362626C-9924-4D18-B334-713F6BC82B31Q36662879-51DED476-CEC3-4092-8AC4-A49195DA26ABQ36676527-855F9D36-684D-4470-BDE5-DA1205CCEDA1Q36763160-594F0665-FE0E-409D-BE75-C3CB5687C465Q36803454-2AE50A34-EE52-4517-A120-232F249E4215Q37013956-03F170A6-CB8E-475D-9926-F497E39FAD6DQ37150339-69D3790C-C6CE-46A2-84D4-783FF8520269Q37161917-712666B9-55BA-4AD0-BEB2-EF1F11D3E896Q37230298-40F743A8-3305-4C8B-A9B6-3850FB886D24Q37249418-DDAC1B36-60B4-43A1-A941-4CF02FFD99E7Q37298637-A913B919-EC4F-4D70-955E-193A8D5AF0FFQ37417511-BE257F4C-7980-4750-960A-F792CBBF3972Q37551105-27E53016-EA25-4399-9E5E-7812D4940E98
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacokinetics of antiretrovirals in pregnant women.
@ast
Pharmacokinetics of antiretrovirals in pregnant women.
@en
type
label
Pharmacokinetics of antiretrovirals in pregnant women.
@ast
Pharmacokinetics of antiretrovirals in pregnant women.
@en
prefLabel
Pharmacokinetics of antiretrovirals in pregnant women.
@ast
Pharmacokinetics of antiretrovirals in pregnant women.
@en
P1476
Pharmacokinetics of antiretrovirals in pregnant women.
@en
P2093
Edmund Capparelli
Mark Mirochnick
P304
P356
10.2165/00003088-200443150-00002
P577
2004-01-01T00:00:00Z
P6179
1021251857